• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经源性逼尿肌过度活动的药物治疗

Pharmacotherapy for neurogenic detrusor overactivity.

作者信息

Chancellor Michael B, Anderson Rodney U, Boone Timothy B

机构信息

Department of Urology, University of Pittsburgh School of Medicine, 3471 Fifth Avenue, Pittsburgh, PA 15213, USA.

出版信息

Am J Phys Med Rehabil. 2006 Jun;85(6):536-45. doi: 10.1097/01.phm.0000219229.92056.c2.

DOI:10.1097/01.phm.0000219229.92056.c2
PMID:16715024
Abstract

Chancellor MB, Anderson RU, Boone TB: Pharmacotherapy for neurogenic detrusor overactivity. Am J Phys Med Rehabil 2006;85:536-545. Patients with neurogenic detrusor overactivity are a heterogeneous group with voiding dysfunction secondary to neurologic injury or disease. The neurogenic detrusor overactivity syndrome, which may include urinary frequency, urgency, and incontinence, frequently contributes to a loss of independence, or even institutionalization. Urodynamic assessment provides the best method of quantifying and classifying neurogenic detrusor overactivity dysfunction in patients with primary diagnoses as diverse as Parkinson's disease, cerebral palsy, multiple sclerosis, spinal cord injury, and spina bifida. For many patients, management of urinary symptoms includes pharmacotherapy with an anticholinergic agent. Several novel approaches to managing neurogenic detrusor overactivity, including intravesical instillation of anticholinergic agents, vanilloids, and neurotoxins, are being investigated. For most patients, however, flexible dosing with an anticholinergic agent, with clean intermittent catheterization when indicated, has been shown to reduce the risks of urologic complications, improve levels of continence, and enhance patient quality of life in both children and adults.

摘要

钱塞勒·MB、安德森·RU、布恩·TB:神经源性逼尿肌过度活动的药物治疗。《美国物理医学与康复》2006年;85:536 - 545。神经源性逼尿肌过度活动患者是一个异质性群体,存在继发于神经损伤或疾病的排尿功能障碍。神经源性逼尿肌过度活动综合征,可能包括尿频、尿急和尿失禁,常常导致患者失去独立生活能力,甚至需要住进护理机构。尿动力学评估为量化和分类神经源性逼尿肌过度活动功能障碍提供了最佳方法,这些患者的初始诊断多种多样,如帕金森病、脑瘫、多发性硬化症、脊髓损伤和脊柱裂。对许多患者而言,排尿症状的管理包括使用抗胆碱能药物进行药物治疗。目前正在研究几种治疗神经源性逼尿肌过度活动的新方法,包括膀胱内灌注抗胆碱能药物、香草酸类药物和神经毒素。然而,对大多数患者来说,灵活使用抗胆碱能药物,并在必要时进行清洁间歇性导尿,已被证明可降低泌尿系统并发症的风险,提高控尿水平,并改善儿童和成人患者的生活质量。

相似文献

1
Pharmacotherapy for neurogenic detrusor overactivity.神经源性逼尿肌过度活动的药物治疗
Am J Phys Med Rehabil. 2006 Jun;85(6):536-45. doi: 10.1097/01.phm.0000219229.92056.c2.
2
European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity.欧洲对200例因神经源性逼尿肌过度活动导致尿失禁而接受肉毒杆菌A毒素注射到逼尿肌治疗的经验。
Eur Urol. 2004 Apr;45(4):510-5. doi: 10.1016/j.eururo.2003.12.004.
3
Intravesical vanilloids and neurogenic incontinence: ten years experience.膀胱内香草酸类药物与神经源性尿失禁:十年经验
Urol Int. 2004;72(2):145-9. doi: 10.1159/000075969.
4
The overactive bladder: review of current pharmacotherapy in adults. Part 2: treatment options in cases refractory to anticholinergics.膀胱过度活动症:成人当前药物治疗综述。第2部分:抗胆碱能药物难治性病例的治疗选择。
Expert Opin Pharmacother. 2006 Apr;7(5):529-38. doi: 10.1517/14656566.7.5.529.
5
Detrusor overactivity in spina bifida: how long does it need to be treated?脊柱裂患者逼尿肌过度活动症:需要治疗多长时间?
Neurourol Urodyn. 2004;23(7):685-8. doi: 10.1002/nau.20044.
6
Urodynamic effects of intravesical nociceptin/orphanin FQ in neurogenic detrusor overactivity: a randomized, placebo-controlled, double-blind study.膀胱内注射孤啡肽/孤啡肽FQ对神经源性逼尿肌过度活动的尿动力学影响:一项随机、安慰剂对照、双盲研究。
Urology. 2003 May;61(5):946-50. doi: 10.1016/s0090-4295(02)02587-6.
7
Daily intravesical instillation of 1 mg nociceptin/orphanin FQ for the control of neurogenic detrusor overactivity: a multicenter, placebo controlled, randomized exploratory study.
J Urol. 2006 Nov;176(5):2098-102. doi: 10.1016/j.juro.2006.07.025.
8
Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study.A型肉毒杆菌毒素是治疗神经源性尿失禁的一种安全有效的方法:一项单次治疗、随机、安慰剂对照的6个月研究结果。
J Urol. 2005 Jul;174(1):196-200. doi: 10.1097/01.ju.0000162035.73977.1c.
9
Refractory neurogenic detrusor overactivity.难治性神经源性逼尿肌过度活动
Int J Clin Pract Suppl. 2006 Dec(151):22-6. doi: 10.1111/j.1742-1241.2006.01182.x.
10
Intravesical resiniferatoxin for patients with neurogenic detrusor overactivity.膀胱内注射树脂毒素治疗神经源性逼尿肌过度活动症患者。
Int J Urol. 2004 Apr;11(4):200-5. doi: 10.1111/j.1442-2042.2003.00782.x.

引用本文的文献

1
Efficiency and Safety of Noninvasive and Intravesical Therapy for Adult Neurogenic Lower Urinary Tract Dysfunction: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials.成人神经源性下尿路功能障碍的非侵入性和膀胱内治疗的有效性和安全性:一项随机对照试验的系统评价和网状Meta分析
Drugs. 2025 May;85(5):677-693. doi: 10.1007/s40265-025-02171-3. Epub 2025 Apr 1.
2
Urodynamic and Frequency-Volume Chart Parameters Influencing Anticholinergic Resistance in Patients With Neurogenic Detrusor Overactivity.影响神经源性逼尿肌过度活动患者抗胆碱能药物抵抗的尿动力学和频率-容量图参数
Int Neurourol J. 2024 Sep;28(3):232-238. doi: 10.5213/inj.2448310.155. Epub 2024 Sep 30.
3
Conservative Bladder Management and Medical Treatment in Chronic Spinal Cord Injury Patients.
慢性脊髓损伤患者的膀胱保守管理与药物治疗
J Clin Med. 2023 Mar 3;12(5):2021. doi: 10.3390/jcm12052021.
4
Bladder Management Strategies for Urological Complications in Patients with Chronic Spinal Cord Injury.慢性脊髓损伤患者泌尿系统并发症的膀胱管理策略
J Clin Med. 2022 Nov 20;11(22):6850. doi: 10.3390/jcm11226850.
5
Characterization and in vivo efficacy of a heptapeptide ODT formulation for the treatment of neurogenic bladder dysfunction.一种用于治疗神经原性膀胱功能障碍的七肽 ODT 制剂的特征描述和体内疗效。
Int J Pharm. 2018 Jan 30;536(1):397-404. doi: 10.1016/j.ijpharm.2017.11.036. Epub 2017 Nov 28.
6
Pharmacotherapy for Pediatric Neurogenic Bladder.小儿神经源性膀胱的药物治疗
Paediatr Drugs. 2017 Oct;19(5):463-478. doi: 10.1007/s40272-017-0249-x.
7
Real life persistence rate with antimuscarinic treatment in patients with idiopathic or neurogenic overactive bladder: a prospective cohort study with solifenacin.特发性或神经源性膀胱过度活动症患者使用抗毒蕈碱药物治疗的实际持续率:一项关于索利那新的前瞻性队列研究
BMC Urol. 2017 Apr 13;17(1):30. doi: 10.1186/s12894-017-0216-4.
8
Neurogenic lower urinary tract dysfunction: evaluation and management.神经源性下尿路功能障碍:评估与管理
J Neurol. 2016 Dec;263(12):2555-2564. doi: 10.1007/s00415-016-8212-2. Epub 2016 Jul 11.
9
Patients With Neurogenic Lower Urinary Tract Dysfunction Following Spinal Cord Injury Are at Increased Risk of Developing Type 2 Diabetes Mellitus: A Population-Based Cohort Study.脊髓损伤后神经源性下尿路功能障碍患者患2型糖尿病的风险增加:一项基于人群的队列研究。
Medicine (Baltimore). 2016 Jan;95(2):e2518. doi: 10.1097/MD.0000000000002518.
10
Neurogenic Bladder and Urodynamic Outcomes in Patients with Spinal Cord Myelopathy.脊髓病患者的神经源性膀胱及尿动力学结果
Top Spinal Cord Inj Rehabil. 2015 Summer;21(3):250-6. doi: 10.1310/sci2103-250. Epub 2015 Jul 29.